SOURCE: Sunwin International Neutraceuticals, Inc.

October 15, 2008 08:00 ET

Sunwin International Sees Australia's Approval of Stevia Opening a Substantial New Market Opportunity

Australia Approves Stevia for Use as a Sweetener in Australia and New Zealand

QUFU, CHINA--(Marketwire - October 15, 2008) - Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie stevia in China, applauds the recent decision by the Australian food and drug regulatory authority (FSANZ) to approve stevia as a sweetener in Australia and New Zealand. Management is excited to explore the new market opportunities which it expects to capitalize on as a result of this important approval for stevia.

The FSANZ review process evaluated current worldwide safety studies of stevia products which showed no adverse health risks, as well as use in Japan where stevia has been a common sweetener for more than 35 years without any reported adverse effects.

The FSANZ approval allows steviol glycosides to be used in any food or drink that uses sugar as a sweetener. It also allows the replacement of chemical sweeteners in diet drinks with all natural stevia sweeteners. The chemical sweeteners used in these diet drinks have been linked to numerous health concerns. We believe that stevia is seen as an important natural sweetener choice in the fight against obesity and type II diabetes which has become more prevalent in industrialized nations. For example, a soda sweetened with stevia could contain 99.5 % fewer calories than the same soda sweetened with sugar.

President and Chairman Laiwang Zhang, commented, "Sunwin is pleased with the FSANZ approval taking stevia one step closer in the effort to make it globally available. Stevia is a safe and natural alternative to sugar for people needing low sugar or low calorie diets. We believe that decades of stevia use confirm its safety and suitability to replace sugar in beverages and foods, including those that require baking or cooking where chemical sweeter replacements are not suitable. As a top global producer and wholesaler, we are pleased to see this market expansion opportunity and yet another major confirmation of stevia's safety for countries presently considering full approval of stevia as a sweetener. We are hopeful Australia's decision will add further support for the U.S. FDA to acknowledge stevia to be Generally Recognized as Safe (GRAS) in the U.S. in the very near future. GRAS status will permit stevia to be used in food and beverage products in the U.S., which we expect could triple stevia sales. We are extremely excited with this development, and expect that this will add further momentum to the use of stevia in additional countries worldwide."

Company Background:

Sunwin International Neutraceuticals, Inc. engages in the areas of essential traditional Chinese medicine, zero calorie natural sweeteners (stevia), and veterinary medicines and feeds prepared from 100 percent organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. For more info about Sunwin, please visit http://www.sunwininternational.com

Safe Harbor Statement

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations regarding new markets for stevia, our belief about the affects of stevia in the fight against obesity and its safety and suitability to replace sugar in beverages and food, our expectations regarding GRAS recognition by the FDA and expectations regarding future stevia sales. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations: the business operating risks and new and competing sugar substitutes.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2007 and our reports on Form 10-Q.

Contact Information